Page last updated: 2024-10-21

(alpha-carboxycyclopropyl)glycine and Chronic Disease

(alpha-carboxycyclopropyl)glycine has been researched along with Chronic Disease in 1 studies

(alpha-carboxycyclopropyl)glycine: structure given in first source; glutamate receptor agonist

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dolan, S1
Nolan, AM1

Other Studies

1 other study available for (alpha-carboxycyclopropyl)glycine and Chronic Disease

ArticleYear
Behavioural evidence supporting a differential role for group I and II metabotropic glutamate receptors in spinal nociceptive transmission.
    Neuropharmacology, 2000, Apr-27, Volume: 39, Issue:7

    Topics: Amino Acids, Dicarboxylic; Animals; Behavior, Animal; Chronic Disease; Cycloleucine; Excitatory Amin

2000